Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




First-Of-Its-Kind 4K Endoscope for Arthroscopic Surgical Procedures Launched Globally

By HospiMedica International staff writers
Posted on 07 Nov 2022

A first-of-its-kind 4K endoscope designed for use in arthroscopic surgical procedures is revolutionizing the market by delivering 4K optics in a single-use device – providing first-time quality for every procedure. More...

Integrated Endoscopy (Irvine, CA, USA) has launched its second generation NUVIS (pronounced “nu-vee”) Single-Use Arthroscope, a first-of-its-kind 4K endoscope designed for use in arthroscopic surgical procedures. The release of the Gen II NUVIS features a patent pending simplified optical train design which reduces the number of optical elements by over 60% while boosting image quality to 4K. Not only is the image quality superior, but the Gen II NUVIS will also be substantially faster and less expensive to manufacture and amenable to high-volume automation.

As part of the Gen II launch, Integrated Endoscopy is releasing multiple versions of NUVIS to make the technology compatible with most cannulas on the market. NUVIS is also compatible with most installed video towers and will support a 4K camera system without requiring additional capital equipment. NUVIS has a built-in battery powered LED, which eliminates the light box and bulky light cord. Integrated Endoscopy’s Gen II NUVIS single-use, 4K, battery operated cordless arthroscope is FDA 501(k) cleared, CE marked, and is being registered in a number of markets around the world. As manufacturing capacity increases, the company will continue to expand its global distribution network to provide this unique technology to the arthroscopic surgical community.

“The release of the Gen II NUVIS is a huge milestone for the company in terms of image quality and compatibility,” said Brad Sharp, Integrated Endoscopy’s CEO. “Our next-gen arthroscope also provides a substantial decrease in manufacturing costs while simultaneously increasing ease of manufacturability. The demand we have seen for NUVIS far exceeds our current manufacturing capacity, so the efficiencies the Gen II NUVIS affords will greatly aid in shortening production time and costs. With a global market of over 1.5 million units per month, increasing our manufacturing capacity will be a major focus for the company moving forward.”

Related Links:

Integrated Endoscopy


Gold Member
12-Channel ECG
CM1200B
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Semi‑Automatic Defibrillator
Heart Save AED (ED300)
Electric Bed
DIXION Intensive Care Bed
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: A smartphone application displays a glucose concentration that was measured using the new sensor (Photo courtesy of Chuchu Chen and Yonghao Fu)

Wearable Device for Diabetics Could Replace Continuous Glucose Monitoring Systems

Monitoring blood glucose is essential for people with diabetes to prevent complications and maintain long-term health. Current continuous glucose monitoring systems require needles inserted under the skin,... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.